A booth for Merck Sharp & Dohme at the Medical Equipment and Healthcare Products exhibition during the third China International Import Expo in Shanghai, east China, Nov. 5, 2020. [Photo/VCG]
Revenue in H1 2021 (pharmaceutical segment): $22.03 billion
Go to Forum >>0 Comment(s)